Table 2.
Sensitivity, specificity, PPV, and NPV of various clinical and biochemical predictors in accurately predicting presence of persistent choledocholithiasis
| Sensitivity | Specificity | PPV | NPV | |
|---|---|---|---|---|
| Bili >4 mg/dL (first set) | .301 | .825 | .558 | .603 |
| Bili >4 mg/dL (second set) | .223 | .856 | .529 | .603 |
| Stone on ultrasound | .218 | .935 | .708 | .623 |
| Decrease in ALT and bilirubin >30% each on second set labs | .870 | .150 | .427 | .611 |
| Biliary pancreatitis | .417 | .689 | .439 | .670 |